245 related articles for article (PubMed ID: 24874813)
41. Microbial technologies for the discovery of novel bioactive metabolites.
Donadio S; Monciardini P; Alduina R; Mazza P; Chiocchini C; Cavaletti L; Sosio M; Puglia AM
J Biotechnol; 2002 Nov; 99(3):187-98. PubMed ID: 12385708
[TBL] [Abstract][Full Text] [Related]
42. Old and new glycopeptide antibiotics: From product to gene and back in the post-genomic era.
Marcone GL; Binda E; Berini F; Marinelli F
Biotechnol Adv; 2018; 36(2):534-554. PubMed ID: 29454983
[TBL] [Abstract][Full Text] [Related]
43. Biosynthesis pathways for deoxysugars in antibiotic-producing actinomycetes: isolation, characterization and generation of novel glycosylated derivatives.
Salas JA; Méndez C
J Mol Microbiol Biotechnol; 2005; 9(2):77-85. PubMed ID: 16319497
[TBL] [Abstract][Full Text] [Related]
44. Antibacterial agents from actinomycetes - a review.
Mahajan GB; Balachandran L
Front Biosci (Elite Ed); 2012 Jan; 4(1):240-53. PubMed ID: 22201868
[TBL] [Abstract][Full Text] [Related]
45. Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms.
Marshall CG; Lessard IA; Park I; Wright GD
Antimicrob Agents Chemother; 1998 Sep; 42(9):2215-20. PubMed ID: 9736537
[TBL] [Abstract][Full Text] [Related]
46. Marine actinomycetes: an ongoing source of novel bioactive metabolites.
Subramani R; Aalbersberg W
Microbiol Res; 2012 Dec; 167(10):571-80. PubMed ID: 22796410
[TBL] [Abstract][Full Text] [Related]
47. Triggers and cues that activate antibiotic production by actinomycetes.
Zhu H; Sandiford SK; van Wezel GP
J Ind Microbiol Biotechnol; 2014 Feb; 41(2):371-86. PubMed ID: 23907251
[TBL] [Abstract][Full Text] [Related]
48. Natural products as a source of drug leads to overcome drug resistance.
Silver LL
Future Microbiol; 2015; 10(11):1711-8. PubMed ID: 26517443
[TBL] [Abstract][Full Text] [Related]
49. Actinobacteriological research in India.
Velho-Pereira S; Kamat NM
Indian J Exp Biol; 2013 Aug; 51(8):573-96. PubMed ID: 24228382
[TBL] [Abstract][Full Text] [Related]
50. Antibiotic discovery in the twenty-first century: current trends and future perspectives.
Donadio S; Maffioli S; Monciardini P; Sosio M; Jabes D
J Antibiot (Tokyo); 2010 Aug; 63(8):423-30. PubMed ID: 20551985
[TBL] [Abstract][Full Text] [Related]
51. Eliciting antibiotics active against the ESKAPE pathogens in a collection of actinomycetes isolated from mountain soils.
Zhu H; Swierstra J; Wu C; Girard G; Choi YH; van Wamel W; Sandiford SK; van Wezel GP
Microbiology (Reading); 2014 Aug; 160(Pt 8):1714-1725. PubMed ID: 24794971
[TBL] [Abstract][Full Text] [Related]
52. Detection of antibiotics synthetized in microfluidic picolitre-droplets by various actinobacteria.
Mahler L; Wink K; Beulig RJ; Scherlach K; Tovar M; Zang E; Martin K; Hertweck C; Belder D; Roth M
Sci Rep; 2018 Aug; 8(1):13087. PubMed ID: 30166560
[TBL] [Abstract][Full Text] [Related]
53. Resistance-Guided Discovery of Elfamycin Antibiotic Producers with Antigonococcal Activity.
Yarlagadda V; Medina R; Johnson TA; Koteva KP; Cox G; Thaker MN; Wright GD
ACS Infect Dis; 2020 Dec; 6(12):3163-3173. PubMed ID: 33164482
[TBL] [Abstract][Full Text] [Related]
54. Strategies for the Discovery and Development of New Antibiotics from Natural Products: Three Case Studies.
Herrmann J; Lukežič T; Kling A; Baumann S; Hüttel S; Petković H; Müller R
Curr Top Microbiol Immunol; 2016; 398():339-363. PubMed ID: 27738913
[TBL] [Abstract][Full Text] [Related]
55. Evolving Antibiotics against Resistance: a Potential Platform for Natural Product Development?
Wollein Waldetoft K; Gurney J; Lachance J; Hoskisson PA; Brown SP
mBio; 2019 Dec; 10(6):. PubMed ID: 31874919
[TBL] [Abstract][Full Text] [Related]
56. Production of hybrid glycopeptide antibiotics in vitro and in Streptomyces toyocaensis.
Solenberg PJ; Matsushima P; Stack DR; Wilkie SC; Thompson RC; Baltz RH
Chem Biol; 1997 Mar; 4(3):195-202. PubMed ID: 9115410
[TBL] [Abstract][Full Text] [Related]
57. Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12.
Hosaka T; Ohnishi-Kameyama M; Muramatsu H; Murakami K; Tsurumi Y; Kodani S; Yoshida M; Fujie A; Ochi K
Nat Biotechnol; 2009 May; 27(5):462-4. PubMed ID: 19396160
[TBL] [Abstract][Full Text] [Related]
58. Structural biological study of self-resistance determinants in antibiotic-producing actinomycetes.
Sugiyama M
J Antibiot (Tokyo); 2015 Sep; 68(9):543-50. PubMed ID: 25873321
[TBL] [Abstract][Full Text] [Related]
59. Bioinformatic evaluation of the secondary metabolism of antistaphylococcal environmental bacterial isolates.
Wyatt MA; Lee J; Ahilan Y; Magarvey NA
Can J Microbiol; 2013 Jul; 59(7):465-71. PubMed ID: 23826955
[TBL] [Abstract][Full Text] [Related]
60. Balhimycin, a new glycopeptide antibiotic produced by Amycolatopsis sp. Y-86,21022. Taxonomy, production, isolation and biological activity.
Nadkarni SR; Patel MV; Chatterjee S; Vijayakumar EK; Desikan KR; Blumbach J; Ganguli BN; Limbert M
J Antibiot (Tokyo); 1994 Mar; 47(3):334-41. PubMed ID: 8175486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
